BAJAJ BROKING

Notification close image
No new Notification messages
card image
Accretion Pharmaceuticals IPO is Open!
Apply for the Accretion Pharmaceuticals IPO through UPI in just minutes.
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

MSCI November 2024 Review: New Additions Announced

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

MSCI’s November 2024 review introduces five companies to its Standard Index and thirteen to the Small Cap Index, expected to drive substantial investments, with Voltas and Alkem leading in anticipated inflows.

MSCI news today

The MSCI (Morgan Stanley Capital International) announced the results of its highly anticipated November 2024 review, bringing in substantial changes to its indices. MSCI’s Standard Index will now feature five new additions, including prominent Indian companies Voltas, Alkem Laboratories, Oberoi Realty, Bombay Stock Exchange (BSE), and Kalyan Jewellers. The Small Cap Index has also expanded, welcoming thirteen new companies to enhance diversity in the MSCI's portfolio of investments. This review is a key periodic assessment that reflects the evolving market landscape, providing insights into emerging growth opportunities within the global investment sector.

VOLTAS LTD

Trade

1261.1-1.30 (-0.10 %)

Updated - 16 May 2025
1270.00day high
DAY HIGH
1252.50day low
DAY LOW
580718
VOLUME (BSE)

Five key additions to the MSCI Standard Index

With this latest inclusion, the MSCI Standard Index positions five additional companies to benefit from heightened exposure and potential foreign capital inflows. Voltas, known for its dominance in the Indian consumer goods sector, emerges as a notable addition. Industry experts anticipate that the company could attract over $300 million in investments due to its inclusion in the index, signifying global investors’ confidence in its market position. Alkem Laboratories, another prominent entrant, is set to receive an estimated $200 million in inflows, enhancing its financial foothold in the competitive pharmaceutical sector.

Joining these market leaders, Oberoi Realty, a well-recognised name in Indian real estate, stands to gain significant foreign investor attention. Kalyan Jewellers and the Bombay Stock Exchange (BSE) also solidify their positions within the global investment landscape with this inclusion, expected to attract capital of over $220 million to the BSE alone, according to projections.

Small cap index gains 13 new companies

The MSCI Small Cap Index, a critical component for emerging companies looking to scale within international markets, expands with thirteen new additions this November. While specific names remain under wraps, the newly included companies represent diverse sectors and are likely to capture attention from investors seeking high-growth opportunities. This increased representation highlights MSCI's commitment to broadening its exposure to promising small-cap companies.

Implications for MSCI share price

MSCI’s index rebalancing and expansion are anticipated to have a positive impact on its share price, with the potential to attract increased trading volumes. As companies within these indices gain more investment exposure, MSCI’s credibility as a benchmark provider for investors worldwide continues to strengthen, benefiting from its strategic diversification.

MSCI’s November 2024 review underscores the firm’s focus on market dynamism and investment diversity. The inclusion of leading Indian companies within the MSCI Standard Index highlights India’s growing significance in the global financial landscape. These changes, particularly for Voltas, Alkem, and BSE, are set to influence foreign inflows significantly, promising enhanced capital growth for these companies and sustained interest in MSCI’s indices worldwide.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|